The New Belgian Companies and Associations Code: What is changing?
Event | 03.27.19, 9:00 AM UTC - 1:30 PM UTC
Address
Crowell & Moring
Rue Joseph Stevens 7, 1000 Brussels
The new Companies and Associations Code has been approved by the Belgian Parliament on February 28, 2019. This Code replaces the current Companies Code as well as the Law on Associations and Foundations and the Law on Professional Associations. It extensively rewrites the rules regulating companies, associations, and foundations.
The new Code will enter into force on May 1, 2019.
During this seminar we will provide an overview of the major changes brought by the new Companies and Associations Code. Topics will include:
- The corporate forms remaining after the reform
- The new BV/SRL and the abolishment of capital requirement
- The new NV/SA
- Governance models in the BV/SRL and NV/SA
- Rules on directors’ liability
- Voting rights
- Conflicts between shareholders
- The integration of the rules for associations and foundations
- Entry into force and transitional implementation process
One of the innovations of the reform is the introduction of a cap on the liability of directors, which opens perspectives for review of D&O insurance policies. We have invited a speaker of Zurich Insurance to discuss D&O risks and insurance opportunities.
Agenda
9:00 – 9:30: Welcome and Breakfast
9:30 – 11:00: Major Changes of the Reform – Part I
11:00 – 11:30: Coffee break
11:30 – 12:30: Major changes of the reform – Part II / Directors’ & Officers’ Liability and Risk Management
12:30 – 13:30: Sandwich lunch
Languages: FR/NL Alternatively
Presented by: IJE/IBJ and Crowell & Moring in corporation with Zurich Insurance
For questions about this seminar, please contact Danica Schiefer.
For more information, please visit these areas: Regulatory — Brussels Practice
Insights
Event | 02.25.25
Charting a Path for Compliance in Life Sciences
Join us for an interactive and educational event tailored for biotech leaders seeking to ensure security compliance while leveraging the power of Amazon Web Services (AWS). This session will dive into the critical elements of designing secure, scalable, and compliant systems for biotech operations, from research and development to clinical trials and beyond.
Event | 02.20.25
Event | 02.18.25 - 02.20.25
Event | 12.05.24